ES8605770A1 - Procedimiento para obtener un polipeptido purificado - Google Patents

Procedimiento para obtener un polipeptido purificado

Info

Publication number
ES8605770A1
ES8605770A1 ES542309A ES542309A ES8605770A1 ES 8605770 A1 ES8605770 A1 ES 8605770A1 ES 542309 A ES542309 A ES 542309A ES 542309 A ES542309 A ES 542309A ES 8605770 A1 ES8605770 A1 ES 8605770A1
Authority
ES
Spain
Prior art keywords
image
denotes
agents containing
peptides
isolation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES542309A
Other languages
English (en)
Other versions
ES542309A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of ES8605770A1 publication Critical patent/ES8605770A1/es
Publication of ES542309A0 publication Critical patent/ES542309A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/06—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/26—Containing cys-cys disulfide bridge between nonadjacent cysteine residues

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE UN POLIPEPTIDO EN ESTADO PURO, DE FORMULA (I), EN LA QUE R REPRESENTA HIDROGENO O EL GRUPO SO3H. CONSISTE EN LA SEPARACION DEL POLIPEPTIDO A PARTIR DE HELMINTOS DEL ORDEN DE LOS GNATOBDELIDOS DEL GENERO HIRUDO, CON LA COMPOSICION DE AMINOACIDOS SIGUIENTE: 9 ACIDO ASPARGINICO, 5 TREONINA, 4 RESINA, 13 ACIDO GLUTAMICO, 3 PROLINA, 9 GLICINA, 2 VALINA, 6 CISTEINA, 2 ISOLEUCINA, 4 LEUCINA, 2 TIROSINA, 1 FENILALANINA, 3 LISINA Y 1 HISTIDINA, EN DONDE EL GRUPO OH DE UNO DE LOS RADICALES DE LA TIROSINA PUEDE ESTAR ESTERIFICADO CON ACIDO SULFURICO; LA SEPARACION SE EFECTUA CON AYUDA DE UNA COMBINACION DE LOS METODOS CLASICOS. ESTOS COMPUESTOS TIENEN APLICACIONES FARMACOLOGICAS PARA LA PROFILAXIS Y TERAPIA DE PROCESOS TROMBO-EMBOLICOS.
ES542309A 1984-04-18 1985-04-16 Procedimiento para obtener un polipeptido purificado Granted ES542309A0 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3414593 1984-04-18
DE19843438296 DE3438296A1 (de) 1984-04-18 1984-10-19 Neue polypeptide mit blutgerinnungshemmender wirkung, verfahren zu deren herstellung bzw. gewinnung, deren verwendung und diese enthaltende mittel

Publications (2)

Publication Number Publication Date
ES8605770A1 true ES8605770A1 (es) 1985-12-16
ES542309A0 ES542309A0 (es) 1985-12-16

Family

ID=25820510

Family Applications (3)

Application Number Title Priority Date Filing Date
ES542310A Expired ES8605771A1 (es) 1984-04-18 1985-04-16 Procedimiento para preparar un polipeptido
ES542311A Granted ES542311A0 (es) 1984-04-18 1985-04-16 Procedimiento para preparar un polipeptido
ES542309A Granted ES542309A0 (es) 1984-04-18 1985-04-16 Procedimiento para obtener un polipeptido purificado

Family Applications Before (2)

Application Number Title Priority Date Filing Date
ES542310A Expired ES8605771A1 (es) 1984-04-18 1985-04-16 Procedimiento para preparar un polipeptido
ES542311A Granted ES542311A0 (es) 1984-04-18 1985-04-16 Procedimiento para preparar un polipeptido

Country Status (18)

Country Link
US (1) US4668662A (es)
EP (1) EP0158986B1 (es)
JP (1) JP2552263B2 (es)
KR (1) KR930000054B1 (es)
AR (1) AR242800A1 (es)
AU (1) AU580295B2 (es)
CA (1) CA1271298A (es)
DE (2) DE3438296A1 (es)
DK (1) DK171824B1 (es)
ES (3) ES8605771A1 (es)
FI (1) FI851521L (es)
GR (1) GR850942B (es)
HU (1) HU198085B (es)
IE (1) IE60581B1 (es)
IL (1) IL74948A (es)
NO (1) NO851535L (es)
PT (1) PT80301B (es)
ZA (1) ZA852854B (es)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3342139A1 (de) * 1983-11-22 1985-05-30 Ciba-Geigy Ag, Basel Desulfatohirudine, verfahren zu ihrer herstellung und pharmazeutische mittel
EP0168342B1 (de) * 1984-06-14 1991-07-03 Ciba-Geigy Ag Verfahren zur Herstellung von Thrombin-Inhibitoren
DE3506992A1 (de) * 1985-02-27 1986-08-28 Plantorgan Werk Heinrich G.E. Christensen, KG, 2903 Bad Zwischenahn Modifizierte hirudine, verfahren zu deren herstellung und pharmazeutische mittel, die diese wirkstoffe enthalten
DE19775033I2 (de) * 1985-04-11 2011-01-20 Bayer Schering Pharma Ag Hirudin-Derivat.
DE3738541A1 (de) * 1987-11-13 1989-05-24 Hoechst Ag Verfahren zur isolierung und reinigung von hirudin
DE3689525D1 (de) * 1985-07-17 1994-02-24 Hoechst Ag Neue Polypeptide mit blutgerinnungshemmender Wirkung, Verfahren zu deren Herstellung bzw. Gewinnung, deren Verwendung und diese enthaltende Mittel.
GB8530631D0 (en) 1985-12-12 1986-01-22 Ciba Geigy Ag Thrombin inhibitors
US6005071A (en) * 1987-01-23 1999-12-21 Merrell Pharmaceuticals Inc. Anticoagulant peptides
US5789540A (en) * 1987-01-23 1998-08-04 Merrell Pharmaceuticals Inc. Anticoagulant peptides
PT87083B (pt) * 1987-03-28 1992-07-31 Boehringer Ingelheim Int Processo para a preparacao de uma proteina anticoagulante vascular, de adn que codifica para esta proteina e de composicoes farmaceuticas que a contem
US5192745A (en) * 1987-05-21 1993-03-09 Merrell Dow Pharmaceuticals Inc. Cyclic anticoagulant peptides
US5236898A (en) * 1987-05-21 1993-08-17 Merrell Dow Pharmaceuticals Inc. Cyclic anticoagulant peptides
US5256559A (en) * 1988-03-04 1993-10-26 Biogen, Inc. Methods and compositions for inhibiting platelet aggregation
US4971953A (en) * 1988-05-10 1990-11-20 Merrell Dow Pharmaceuticals Anticoagulant peptide alcohols
NZ228995A (en) * 1988-05-10 1992-03-26 Merrell Dow Pharma Hirudin peptide derivatives and pharmaceutical compositions
WO1989011290A1 (en) * 1988-05-27 1989-11-30 Magainin Sciences, Inc. Amphiphilic peptides and use thereof
US5114921A (en) * 1988-05-27 1992-05-19 The Children's Hospital Of Philadelphia Amphiphilic peptides and use thereof
DE3819078A1 (de) * 1988-06-04 1989-12-07 Hoechst Ag Amblyommin, ein neuer wirkstoff fuer die antikoagulationstherapie
DE3819079A1 (de) * 1988-06-04 1989-12-07 Hoechst Ag Hirudin-derivate mit verzoegerter wirkung
DE58907266T2 (de) * 1988-06-11 1994-09-29 Ciba Geigy Ag Polypeptide mit einer die Koagulierung hemmenden Wirkung.
US5268296A (en) * 1988-06-11 1993-12-07 Ciba-Geigy Corporation DNA vector and recombinant host cell for production of hirullin P6 and P18
US5167960A (en) * 1988-08-03 1992-12-01 New England Deaconess Hospital Corporation Hirudin-coated biocompatible substance
US5112615A (en) * 1988-08-03 1992-05-12 New England Deaconess Hospital Corporation Soluble hirudin conjugates
DE3835815A1 (de) * 1988-10-21 1990-04-26 Hoechst Ag Neue isohirudine
US4861865A (en) * 1989-01-23 1989-08-29 Washington University Novel antithrombin peptide
US5254535A (en) * 1989-04-17 1993-10-19 The Children's Hospital Of Pennsylvania Composition and treatment with biologically active peptides and antibiotic
US5179196A (en) * 1989-05-04 1993-01-12 Sri International Purification of proteins employing ctap-iii fusions
US5192747A (en) * 1989-10-03 1993-03-09 Merrell Dow Pharmaceuticals Inc. Anticoagulant peptides
DE3939801A1 (de) * 1989-12-01 1991-06-06 Basf Ag Neue proteine und ihre herstellung
WO1991012015A1 (en) * 1990-02-08 1991-08-22 Magainin Sciences Inc. Biologically active amphiphilic peptides and method of inhibiting growth of target cells, virus or virally-infected cell
US5459237A (en) * 1990-02-08 1995-10-17 Magainin Pharmaceuticals Inc. Peptide compositions and uses therefor
US5792831A (en) * 1990-02-08 1998-08-11 Magainin Pharmaceuticals Inc. Analogues of magainin peptides containing D-amino acids
AU641215B2 (en) * 1990-02-13 1993-09-16 Merrell Dow Pharmaceuticals Inc. Stabilized sulfonate, sulfate, phosphonate and phosphate derivatives of hirudin
DE4009268A1 (de) * 1990-03-22 1991-09-26 Consortium Elektrochem Ind Sekretion von hirudinderivaten
JPH05507273A (ja) * 1990-05-14 1993-10-21 マゲイニン　サイエンセズ　インコーポレーテッド Ｄアミノ酸残基を有する生物活性ペプチドの組成物およびそれによる治療方法
US5208220A (en) * 1990-06-27 1993-05-04 Magainin Pharmaceuticals, Inc. Composition and treatment with biologically active peptides and antibiotics which inhibit DNA gyrase
WO1992000090A1 (en) * 1990-06-27 1992-01-09 Magainin Pharmaceuticals Inc. Composition and treatment with biologically active peptides and antibiotics which inhibit dna gyrase
US5118790A (en) * 1990-07-24 1992-06-02 Sri International Analogs of hirudin
US5574012A (en) * 1990-07-24 1996-11-12 Merrell Pharmaceuticals Inc. Analogs of hirudin having anti-platelet activity
DK0540574T3 (da) * 1990-07-24 1996-09-30 Merrell Pharma Inc Antikoagulationspeptider
US6514730B1 (en) * 1991-03-21 2003-02-04 Consortium für elektrochemische Industrie GmbH Secretion of hirudin derivatives
WO1993007892A1 (en) * 1991-10-16 1993-04-29 The Children's Hospital Of Philadelphia Composition and treatment with biologically active peptides and antibiotic
DE4140381A1 (de) * 1991-12-07 1993-06-09 Hoechst Ag, 6230 Frankfurt, De Neue synthetische isohirudine mit verbesserter stabilitaet
KR100330465B1 (ko) * 1993-06-11 2002-11-23 메렐 파마슈티칼스 인크. 삼관능성항트롬빈및항혈소판펩티드
NZ270194A (en) * 1994-01-07 1996-05-28 Ciba Geigy Ag Hirustasin, a serine protease inhibitor from hirudo medicinalis
GB9401447D0 (en) 1994-01-26 1994-03-23 Ciba Geigy Ag Pharmaceutical compositions
DE4404168A1 (de) * 1994-02-10 1995-08-17 Hoechst Ag Hirudinderivate und Verfahren zu deren Herstellung
DE19529997C1 (de) 1995-08-16 1997-04-10 Hoechst Ag Verfahren zur Inaktivierung von Carboxypeptidase Y in hirudinhaltigen Kulturbrühen
DE19543737A1 (de) * 1995-11-24 1997-05-28 Hoechst Ag Verfahren zur Ultrafiltration von Peptide oder Proteine enthaltender biologischer Matrices
DE19544233A1 (de) 1995-11-28 1997-06-05 Hoechst Ag Verfahren zur Nutzung des Hefe-ADH II-Promotorsystems zur biotechnologischen Produktion heterologer Proteine in hohen Ausbeuten
DE69624087T2 (de) 1996-01-31 2003-06-05 Sumitomo Bakelite Co. Ltd., Tokio/Tokyo Verfahren zur Herstellung von in Epoxyharz eingekapselter Halbleitervorrichtung
DE19607239A1 (de) 1996-02-27 1997-08-28 Behringwerke Ag Pharmazeutische Zusammensetzung, enthaltend Hirudin und Verfahren zu deren Herstellung
US7795205B2 (en) * 2004-04-12 2010-09-14 Canyon Pharmaceuticals, Inc. Methods for effecting regression of tumor mass and size in a metastasized pancreatic tumor
CN101095697A (zh) * 2006-06-28 2008-01-02 李振国 水蛭和/或地龙分子量5800道尔顿以下的提取物
US9056118B2 (en) * 2007-06-26 2015-06-16 Mudanjiang Youbo Pharmaceutical Co., Ltd. Extract for preventing of treating thrombotic diseases
MX2011005163A (es) * 2008-11-19 2011-06-17 Avantor Performance Mat Inc Nuevos medios cromatograficos a base de ligandos de fenoxialquilo y alcoxi- o fenoxi-fenil-alquilo.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3342139A1 (de) * 1983-11-22 1985-05-30 Ciba-Geigy Ag, Basel Desulfatohirudine, verfahren zu ihrer herstellung und pharmazeutische mittel
WO1985004418A1 (fr) * 1984-03-27 1985-10-10 Transgene S.A. Vecteurs d'expression de l'hirudine, cellules transformees et procede de preparation de l'hirudine
DE3429430A1 (de) * 1984-08-10 1986-02-20 Hoechst Ag, 6230 Frankfurt Gentechnologisches verfahren zur herstellung von hirudin und mittel zur durchfuehrung dieses verfahrens

Also Published As

Publication number Publication date
EP0158986A2 (de) 1985-10-23
IE60581B1 (en) 1994-07-27
DK171824B1 (da) 1997-06-23
US4668662A (en) 1987-05-26
ES8605772A1 (es) 1985-12-16
ES542310A0 (es) 1985-12-16
IE850983L (en) 1985-10-18
JPS60233098A (ja) 1985-11-19
NO851535L (no) 1985-10-21
KR930000054B1 (ko) 1993-01-06
EP0158986B1 (de) 1993-09-15
HUT37806A (en) 1986-02-28
ES8605771A1 (es) 1985-12-16
AU580295B2 (en) 1989-01-12
AU4136485A (en) 1985-10-24
IL74948A (en) 1989-09-10
ES542311A0 (es) 1985-12-16
FI851521A0 (fi) 1985-04-16
EP0158986A3 (en) 1988-09-21
HU198085B (en) 1989-07-28
JP2552263B2 (ja) 1996-11-06
KR850007801A (ko) 1985-12-09
PT80301B (de) 1987-02-10
IL74948A0 (en) 1985-08-30
DE3587576D1 (de) 1993-10-21
ZA852854B (en) 1985-11-27
CA1271298A (en) 1990-07-03
FI851521L (fi) 1985-10-19
DE3438296A1 (de) 1985-11-07
GR850942B (es) 1985-11-25
AR242800A1 (es) 1993-05-31
DK173985A (da) 1985-10-19
PT80301A (de) 1985-05-01
ES542309A0 (es) 1985-12-16
DK173985D0 (da) 1985-04-17

Similar Documents

Publication Publication Date Title
ES8605771A1 (es) Procedimiento para preparar un polipeptido
ES2000216A6 (es) Procedimiento para preparar un polipeptido purificado que tiene propiedades inhibidoras de la coagulacion de la sangre.
EP0151246A3 (en) Polypeptide inhibitor of the activity of alpha-amylase, process for its preparation, its use, and pharmaceutical preparations
DE3166150D1 (en) N-(vinblastinoyl-23) derivatives of amino acids and peptides and their preparation
AU5553790A (en) Cysteine added variants of polypeptides and chemical modifications thereof
ZA858328B (en) Peptides selected from amino acid residues 11 to 23 of vip
IL134982A0 (en) Antibodies which react with polypeptides of cd-44 surface proteins and diagnostic and pharmaceutical compositions prepared therewith
AU6286986A (en) Peptide analogues of mammalian insulin-like growth factor-1
RU94036776A (ru) Домен ингибитора протеазы, днк, вектор, клетка, способ получения ингибитора протеазы, фармацевтическая композиция, применение домена ингибитора протеазы
IL72630A (en) Growth hormone-releasing peptides,their preparation and pharmaceutical preparations therefrom
ES489522A0 (es) Un procedimiento para la preparacion de un polipeptido
DK611386A (da) Recombinant humant fsh, fremgangsmaade til fremstilling deraf og vektorer og celler til anvendelse ved fremgangsmaaden
EP0095873A3 (en) Region-specific determinants for vitamin k dependent bone protein
EP0249412A3 (en) C-terminal alpha-amidating enzyme and process for production and use thereof
AU566208B2 (en) Cyclic peptides having somatostatin activity
EP0261648A3 (en) Cell membrane proteins, compositions containing them and procedure for their preparation
CA2004764A1 (en) Ancrod proteins, their preparation and use
WO1990012807A3 (en) Purified, highly specific antibodies against gene products including retinoblastoma and method
GB2195641A (en) Polypeptide with interleukin-2 activity
NO873751L (no) Lymfocytt-aktiverende polypeptider.
DK652889A (da) Fremgangsmaade til fremstilling af et protein eller polypeptid

Legal Events

Date Code Title Description
MM4A Patent lapsed

Effective date: 19960506